Carla van Herpen
28-09-2021
It is important to unravel the DNA in rare types of cancer; 21% of patients with cancer have a rare form.
Back to newsMore news
GenomeWeb: ‘Dutch Team Looks to Drug Repurposing to Improve Patient Outcomes, Lower Costs’
10-11-2016
The project is an attempt to address the rising healthcare costs associated with new cancer drugs and to identify biomarkers …
In search of the optimal treatment strategy for glioblastoma
30-05-2023
Patients with recurrent glioblastoma have an unfavorable outlook and few treatment options. The recently launched GLOW study should change this …
Whole genome sequencing to improve individual cancer treatment in Finland
10-07-2020
Since August 2019, Docrates, a private cancer center in Finland, uses the whole genome sequencing test from Hartwig Medical Foundation to …
WGS is a helpful addition to our toolbox, alongside the classic HE, IHC and the (broad) NGS panels and should ideally be available in every regional oncology network
Head of the Pathology department, Leiden University Medical Center (LUMC)